Search Results

Argatroban 25 mg  | 99.77%

TargetMol

Argatroban, a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.

More Information Supplier Page

Argatroban 10 mg  | 99.77%

TargetMol

Argatroban, a specific thrombin inhibitor, which is a non-heparin anticoagulant, prevents the formation of thrombi.

More Information Supplier Page

Trapidil 10 mg  | Purity Not Available

TargetMol

Trapidil is a coronary vasodilator agent. It was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.

More Information Supplier Page

Trapidil 25 mg  | Purity Not Available

TargetMol

Trapidil is a coronary vasodilator agent. It was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.

More Information Supplier Page

Trapidil 5 mg  | Purity Not Available

TargetMol

Trapidil is a coronary vasodilator agent. It was originally developed as a vasodilator and anti-platelet agent and has been used to treat patients with ischemic coronary heart, liver, and kidney disease.

More Information Supplier Page

Cetirizine dihydrochloride 100 mg  | 100.00%

TargetMol

Cetirizine dihydrochloride is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventional antihistamines, it does not cause side effects of drowsiness or anticholinergic.

More Information Supplier Page

Cetirizine dihydrochloride 200 mg  | 100.00%

TargetMol

Cetirizine dihydrochloride is an effective second-generation histamine H1 antagonist that is potent in the therapy of allergic rhinitis, confirmed urticaria, and pollen-induced asthma. Unlike other conventional antihistamines, it does not cause side effects of drowsiness or anticholinergic.

More Information Supplier Page